AGP Executive Report
Last update: 4 hours agoNew Dementia Clue: A new blood protein marker, GDF15, may flag dementia risk decades earlier when measured in midlife, offering a potential earlier target for prevention and monitoring. Rett Syndrome Treatment Move: The EU’s CHMP has given a positive opinion for DAYBU (trofinetide) for neurobehavioral symptoms of Rett syndrome in patients aged five and up, with European Commission approval expected next. Cancer Care Update: The EU has approved a perioperative KEYTRUDA plus Padcev regimen for certain bladder cancer patients who can’t receive cisplatin, aiming to cut recurrence and death risk. Reykjavík Cost Cuts: Reykjavík City Hall is restructuring to reduce operating costs, including abolishing offices and cutting staff, with responsibilities shifting across departments. Gender Healthcare Governance: Ireland has set up a Policy and Oversight Group for gender healthcare, citing clinical evidence and learning from services in Iceland and other countries. Kids’ Rights Snapshot: Iceland ranks in the top tier of the KidsRights Index 2026, while Kyrgyzstan and Uzbekistan show mixed results, with healthcare stronger than other child-welfare areas.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
